Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease?BARREIRO-DE ACOSTA, M; GISBERT, J. P.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 2, pp 207-210, issn 0269-2813, 4 p.Article

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabTAXONERA, C; ESTELLES, J; GISBERT, J. P et al.Alimentary pharmacology & therapeutics. 2011, Vol 33, Num 3, pp 340-348, issn 0269-2813, 9 p.Article

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyCHAPARRO, M; BURGUENO, P; GOMEZ SENENT, S et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 2, pp 275-283, issn 0269-2813, 9 p.Article

Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraNUNES, T; ETCHEVERS, M. J; ESTEVE, M et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 7, pp 752-760, issn 0269-2813, 9 p.Article